Search

Deborah Anne Eppstein

from Gualala, CA
Age ~75
Get Report
Also known as:
Deborah A Eppstein, Deborah Dr Eppstein, Deborah A Eppstien
Related to:
Jewel Kurian John, 50A Halpin, 35Jenya EppsteinSally A Wansboro, 59Mark P Eppstein, 61Jonathan A Eppstein, 71Alyssa L Halpin, 35Dorothy K Wansboro
Connected to:
Deborah Eppstein, 64Margaret J Eppstein, 68Timothy M Eppstein, 51Michelle T Eprem, 40Amy L Epright, 47Carl Epright, 43Natasha S Eprim, 39Olga Epshtein, 34Yevgeniy Epshteyn, 33Alexandra C Epsilanty, 65

Deborah Eppstein Phones & Addresses

  • Gualala, CA
  • San Francisco, CA
  • Santa Rosa, CA
  • 5355 Pioneer Fork Rd, Salt Lake Cty, UT 84108 (801) 582-7105 (801) 583-5482
  • 3748 E Emigration Canyon Rd, Salt Lake Cty, UT 84108
  • 1675 Emigration Canyon Rd, Salt Lake City, UT 84108
  • Tucker, GA
  • Palo Alto, CA
  • Sonoma, CA

Work

Company: Q therapeutics Feb 2006 Position: President & ceo

Education

Degree: Doctor of Philosophy (PhD) School / High School: University of Arkansas at Fayetteville 1970 to 1974 Specialities: Biochemistry

Skills

Biotechnology • Fda • Technology Transfer • Lifesciences • Pharmaceutical Industry • Medical Devices • Molecular Biology • Drug Discovery • Commercialization • Start Ups • Patents • Licensing • Biopharmaceuticals • Cancer • Biochemistry • Oncology • Protein Chemistry • R&D • Drug Development • Clinical Development • Drug Delivery • Cell • Immunology • Assay Development • Genomics • Cell Biology • Cell Culture • Biomarkers • Life Sciences • Strategy

Languages

English

Interests

Traveling • Hiking • Swimming • Triathlons

Industries

Biotechnology

Resumes

Resumes

Deborah Eppstein Photo 1

Owner

View page
Location:
1980 Cougar Ln, Santa Rosa, CA 95409
Industry:
Biotechnology
Work:
Q Therapeutics since Feb 2006
President & CEO
Altea Therapeutics 1996 - 2002
CEO
Deltagen Proteomics 1999 - 2001
VP Corporate Development
TheraTech, Inc. (later Watson) 1992 - 1998
TheraTech
Syntex Research 1979 - 1992
Director, Corporate Devp
Education:
University of Arkansas at Fayetteville 1970 - 1974
Doctor of Philosophy (PhD), Biochemistry Grinnell College 1966 - 1970
Bachelor of Arts (B.A.), Biochemistry
Skills:
Biotechnology
Fda
Technology Transfer
Lifesciences
Pharmaceutical Industry
Medical Devices
Molecular Biology
Drug Discovery
Commercialization
Start Ups
Patents
Licensing
Biopharmaceuticals
Cancer
Biochemistry
Oncology
Protein Chemistry
R&D
Drug Development
Clinical Development
Drug Delivery
Cell
Immunology
Assay Development
Genomics
Cell Biology
Cell Culture
Biomarkers
Life Sciences
Strategy
Interests:
Traveling
Hiking
Swimming
Triathlons
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Deborah Eppstein
President
Q Therapeutic Products, Inc
Commercial Physical Research
615 Arapeen Dr, Salt Lake City, UT 84108
(801) 582-5400
Deborah Eppstein
Director
M-Biotech, Inc
Commercial Physical Research · Business Services
9241 Falcon Park Cir, Sandy, UT 84093
(801) 674-8442
Deborah Eppstein
CEO
ALTEA GENOMICS, INC
1202 Gail Dr, Atlanta, GA
5355 Pioneer Frk Rd, Salt Lake City, UT
Deborah Eppstein
CEO
Q THERAPEUTICS, INC
Commercial Physical Research · Research & Development in Biotechnology
615 Arapeen Dr STE 102, Salt Lake City, UT 84108
(801) 582-5400
Deborah Eppstein
Secretary, Senior Vice-President
Altea Development Corp
Electrical/Electronic Manufacturing · Commercial Nonphysical Research · Marketing Research & Public Open Polling
2056 Weems Rd, Tucker, GA 30084
5355 Pioneer Frk Rd, Salt Lake City, UT
(770) 270-9554, (678) 495-3130

Publications

Us Patents

N-[1, (1-1) -Dialkyloxy] - And N- [1, (1-1) -Dialkenyloxy]- Alk-1-Yl-N,N,N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
6387395, May 14, 2002
Filed:
Dec 2, 1994
Appl. No.:
08/348635
Inventors:
Deborah A. Eppstein - Palo Alto CA, 94303
Philip L. Felgner - Palo Alto CA, 94303
Thomas R. Gadek - Palo Alto CA, 94303
Gordon H. Jones - Palo Alto CA, 94303
Richard B. Roman - Palo Alto CA, 94303
International Classification:
A61K 9127
US Classification:
424450, 935 54
Abstract:
This invention relates to compounds of the formula or an optical isomer thereof wherein R and R are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R , R and R are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R , R , and R are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

Methods And Compositions For Expanding, Identifying, Characterizing And Enhancing Potency Of Mammalian-Derived Glial Restricted Progenitor Cells

View page
US Patent:
20120230963, Sep 13, 2012
Filed:
Nov 9, 2010
Appl. No.:
13/508803
Inventors:
Robert Sandrock - San Carlos CA, US
James T. Campanelli - Holladay UT, US
Deborah A. Eppstein - Salt Lake City UT, US
Assignee:
Q Therapeutics, Inc. - Salt Lake City UT
International Classification:
C12N 5/0797
C12N 5/079
A61P 25/28
C40B 30/04
A61K 35/30
A61P 25/00
C12N 13/00
C40B 40/10
US Classification:
424 937, 435325, 4351739, 435378, 435379, 506 18, 506 9, 435377
Abstract:
Methods for producing a population of human-derived glial restricted progenitor cells (GRPs) with decreased potentially unintended or undesired cellular phenotypes and/or decreased standard deviation in the cells of the population are provided. Also provided are antibody panels and gene expression profiles to characterize GRPs and a method for its use in characterizing GRP cells. In addition methods for use of these GRP cells to generate astrocytes and/or oligodendrocytes, to re-myelinate neurons and to treat glial cell related and other neurodegenerative diseases or disorders or injuries or damage to the nervous system are provided. A method to manufacture neural cells depleted of A2B5 positive cells is also provided.

N-.Omega.,(.Omega.-1)-Dialkyloxy)- And N-(.Omega.,(.Omega.-1)-Dialkenyloxy)Alk-1-Yl-N,N,N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
50493868, Sep 17, 1991
Filed:
May 15, 1990
Appl. No.:
7/524257
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
A61F 200
US Classification:
424427
Abstract:
This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4 and R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

N[.Omega.,(.Omega.-1)-Dialkyloxy]- And N-[.Omega.,(.Omega.-1)-Dialkenyloxy]-Alk-1-Yl-N,N,N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
48973556, Jan 30, 1990
Filed:
Oct 29, 1987
Appl. No.:
7/114809
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
C12N 500
US Classification:
4352402
Abstract:
This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4 and R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

N-(.Omega.,(.Omega.-1)-Dialkyloxy)- And N-(.Omega.,(.Omega.-1)-Dialkenyloxy)-Alk-1-Yl-N,N,N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
49467875, Aug 7, 1990
Filed:
Oct 27, 1989
Appl. No.:
7/428815
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
A61K 950
A61K 4502
US Classification:
4352402
Abstract:
This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4 and R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

N-[.Omega.,(.Omega.-1)-Dialkyloxy]- And N-[.Omega.,(.Omega.-1)-Dialkenyloxy]-Alk-1-Yl-N,N,N,-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
53667379, Nov 22, 1994
Filed:
Feb 10, 1993
Appl. No.:
8/015738
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
A61K 3722
A61K 970
C12N 120
B01J 1302
US Classification:
424450
Abstract:
This invention relates to compounds of the formula or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4 and R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

N-[.Omega., (.Omega.-1)-Dialkyloxy]- And N-[.Omega., (.Omega.-1)-Dialkenyloxy]-Alk-1-Yl-N, N, N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
56227124, Apr 22, 1997
Filed:
May 4, 1994
Appl. No.:
8/237807
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
A61F 202
A61K 970
A61K 9127
B01J 1302
US Classification:
424450
Abstract:
This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4, R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino; n is 1 to 8; and X is a pharmaceutically acceptable anion.

N-[1, (1-1)-Dialkyloxy]-And N-[1, (1-1)-Dialkenyloxy]-Alk-1-Yl-N,N,N-Tetrasubstituted Ammonium Lipids And Uses Therefor

View page
US Patent:
55454127, Aug 13, 1996
Filed:
Apr 3, 1995
Appl. No.:
8/415962
Inventors:
Deborah A. Eppstein - Menlo Park CA
Philip L. Felgner - Los Altos CA
Thomas R. Gadek - Oakland CA
Gordon H. Jones - Cupertino CA
Richard B. Roman - Fairhope AL
Assignee:
Syntex (U.S.A.) Inc. - Palo Alto CA
International Classification:
A61K 9127
A61K 970
A61F 202
B01J 1302
US Classification:
424450
Abstract:
This invention relates to compounds of the formula ##STR1## or an optical isomer thereof wherein R. sup. 1 and R. sup. 2 are the same or different and are an alkyl or alkenyl group of 6 to 24 carbon atoms; R. sup. 3, R. sup. 4 and R. sup. 5 are the same or different and are alkyl of 1 to 8 carbon atoms, aryl, aralkyl of 7 to 11 carbon atoms, or when two or three of R. sup. 3, R. sup. 4, and R. sup. 5 are taken together to form quinuclidino, piperidino, pyrrolidino, or morpholino, n is 1 to 8; and X is a pharmaceutically acceptable anion.
Control profile
Deborah Anne Eppstein from Gualala, CA, age ~75 Get Report